We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$28.7B
AUM Growth
+$4.18B
(+17%)
Cap. Flow
-$12B
Cap. Flow
% of AUM
-41.89%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
1,665
New
77
Increased
1,003
Reduced
447
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$63.9M |
| 2 |
iShares MBS ETF
MBB
|
+$57.4M |
| 3 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$57.3M |
| 4 |
iShares S&P 100 ETF
OEF
|
+$54M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.13B |
| 2 |
MakeMyTrip
MMYT
|
+$2.41B |
| 3 |
Trip.com Group
TCOM
|
+$770M |
| 4 |
Yum China
YUMC
|
+$508M |
| 5 |
Alibaba
BABA
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.56% |
| 2 | Communication Services | 9.63% |
| 3 | Consumer Discretionary | 9.36% |
| 4 | Healthcare | 6.11% |
| 5 | Financials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Lexicon Pharmaceuticals
LXRX
$1.04B
| $13.3K | ﹤0.01% |
14,029
+1,933
| +16% | +$1.25K |
|
1452
IPG Photonics
IPGP
$3.57B
| $13.3K | ﹤0.01% |
193
-12
| -6% | -$749 |
|
1453
Rigel Pharmaceuticals
RIGL
$762M
| $12.9K | ﹤0.01% |
690
+101
| +17% | +$1.92K |
|
1454
Riot Platforms
RIOT
$7.21B
| $12.8K | ﹤0.01% |
1,129
-6,909
| -86% | -$58.7K |
|
1455
Aquestive Therapeutics
AQST
$533M
| $12.7K | ﹤0.01% |
3,837
+653
| +21% | +$1.87K |
|
1456
Absci
ABSI
$1.62B
| $12.7K | ﹤0.01% |
4,928
+1,085
| +28% | +$3.05K |
|
1457
Prothena Corp
PRTA
$466M
| $12.6K | ﹤0.01% |
2,079
+278
| +15% | +$2.09K |
|
|
TERN
1458
DELISTED
Terns Pharmaceuticals
TERN
| $12.6K | ﹤0.01% |
3,374
+532
| +19% | +$1.66K |
|
|
AMRN
1459
Amarin Corp
AMRN
$299M
| $12.5K | ﹤0.01% |
773
+103
| +15% | +$1.16K |
|
1460
Prime Medicine
PRME
$575M
| $12.5K | ﹤0.01% |
5,072
+683
| +16% | +$1.05K |
|
1461
Humacyte
HUMA
$148M
| $12.5K | ﹤0.01% |
5,992
+1,856
| +45% | +$3.57K |
|
|
DHC
1462
Diversified Healthcare Trust
DHC
$2.03B
| $12.5K | ﹤0.01% |
3,498
-1,064
| -23% | -$3.07K |
|
1463
Virtu Financial
VIRT
$5.05B
| $12.5K | ﹤0.01% |
279
-10,356
| -97% | -$417K |
|
1464
Altimmune
ALT
$560M
| $12.1K | ﹤0.01% |
3,133
+556
| +22% | +$3.01K |
|
1465
Boston Beer
SAM
$1.9B
| $12K | ﹤0.01% |
+63
| New | +$14.5K |
|
1466
Markel Group
MKL
$22.8B
| $12K | ﹤0.01% |
6
-56
| -90% | -$105K |
|
1467
Corvus Pharmaceuticals
CRVS
$1.27B
| $11.9K | ﹤0.01% |
2,979
+931
| +45% | +$3.39K |
|
1468
Atea Pharmaceuticals
AVIR
$406M
| $11.9K | ﹤0.01% |
3,306
+480
| +17% | +$1.43K |
|
|
BCYC
1469
Bicycle Therapeutics
BCYC
$279M
| $11.8K | ﹤0.01% |
1,705
+241
| +16% | +$1.92K |
|
|
INN
1470
Summit Hotel Properties
INN
$656M
| $11.7K | ﹤0.01% |
2,307
-621
| -21% | -$2.73K |
|
|
ATXS
1471
DELISTED
Astria Therapeutics
ATXS
| $11.7K | ﹤0.01% |
2,180
+274
| +14% | +$1.33K |
|
|
AHRT
1472
AH Realty Trust
AHRT
$506M
| $11.4K | ﹤0.01% |
1,655
-498
| -23% | -$3.46K |
|
1473
Olema Pharmaceuticals
OLMA
$920M
| $11.3K | ﹤0.01% |
2,643
+159
| +6% | +$709 |
|
|
WSR
1474
DELISTED
Whitestone REIT
WSR
| $11.2K | ﹤0.01% |
896
-267
| -23% | -$3.4K |
|
1475
Cartesian Therapeutics
RNAC
$264M
| $11.1K | ﹤0.01% |
4,718
+127
| +3% | +$1.35K |
|
Similar funds
BC
Mirae Asset Global Investments's Q2 2025 Portfolio in Review
As of Q2 2025, Mirae Asset Global Investments held 1,665 positions worth $28.7B, up 17% from $24.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Mirae Asset Global Investments withdrew a net $12B in Q2 2025, closing 86 positions and reducing 447 holdings. Its most notable exit was iShares MSCI ACWI ETF, an estimated $19.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Mirae Asset Global Investments opened a new position in iShares S&P 100 ETF worth $58.9M.
- Mirae Asset Global Investments's largest Q2 2025 buy was iShares S&P 100 ETF: 193,670 shares worth $58.9M.
- Mirae Asset Global Investments added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2025, an estimated $63.9M increase.
- Mirae Asset Global Investments's biggest Q2 2025 reduction was Pinduoduo, cutting an estimated $4.13B.
- Mirae Asset Global Investments fully exited iShares MSCI ACWI ETF in Q2 2025, selling an estimated $19.3M.
- Mirae Asset Global Investments's ten largest holdings make up 36% of its $28.7B portfolio in Q2 2025.
- Mirae Asset Global Investments opened 77 new positions and closed 86 in Q2 2025.
- Mirae Asset Global Investments's portfolio value rose 17% quarter-over-quarter to $28.7B.
Based on Mirae Asset Global Investments's 13F filing for Q2 2025, filed 21 Jul 2025.